Enzymotec Ltd. To Present at Two Upcoming Investor Conferences

MIGDAL HA'EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.

Details for the Company presentation are as follows:

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
[email protected]
[email protected]

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Autheo Opens the Public Economy Behind Its Internet Operating System with THEO
• Zoomcar Announces Voting Results from 2026 Annual Meeting of Stockholders